Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,780 products)
- Chiral Building Blocks(1,241 products)
- Hydrocarbon Building Blocks(6,100 products)
- Organic Building Blocks(61,029 products)
Found 205306 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
4-{[(Furan-2-yl)methyl]amino}-1,2-dihydropyrimidin-2-one
CAS:4-{[(Furan-2-yl)methyl]amino}-1,2-dihydropyrimidin-2-one is a compound that has been shown to be an inhibitor of the enzyme citrate synthase. This inhibition causes a decrease in ATP production and an increase in heat production. 4-{[(Furan-2-yl)methyl]amino}-1,2-dihydropyrimidin-2-one has been used in modelling studies to study the biological properties of the citrate synthase enzyme. The graphical methods used include control agents, energy efficiency, and modelling.Formula:C9H9N3O2Purity:Min. 95%Molecular weight:191.19 g/mol6-Cyclopropyl-2-hydroxynicotinonitrile
CAS:Versatile small molecule scaffoldFormula:C9H8N2OPurity:Min. 95%Molecular weight:160.18 g/molML351
CAS:ML351 is a resolvin, which are lipid mediators that serve as precursors to other compounds. Resolvins have been shown to be active in the central nervous system and cardiovascular system. ML351 binds to an enzyme that is required for the production of these mediators. This binding prevents the enzyme from converting arachidonic acid into prostaglandin H2, leading to irreversible inhibition of this enzyme. ML351 has been shown to inhibit the inflammatory response in cells by preventing the production of pro-inflammatory molecules such as prostaglandins and platelet-activating factor (PAF). It also has potential drug targets in congestive heart failure, cardiac hypertrophy, and nonsteroidal anti-inflammatory drugs.Formula:C15H11N3OPurity:Min. 95%Molecular weight:249.27 g/mol8-Methyl-2,3,4,5-tetrahydro-1H-1-benzazepine
CAS:Versatile small molecule scaffoldFormula:C11H15NPurity:Min. 95%Molecular weight:161.24 g/mol4-Methoxy-N-(3-methylbutyl)aniline
CAS:Versatile small molecule scaffold
Formula:C12H19NOPurity:Min. 95%Molecular weight:193.28 g/mol2-Amino-3-hydroxybenzene-1-sulfonamide
CAS:Versatile small molecule scaffoldFormula:C6H8N2O3SPurity:Min. 95%Molecular weight:188.21 g/moltert-Butyl N-[(2R)-2-azidopropyl]carbamate
CAS:Versatile small molecule scaffoldFormula:C8H16N4O2Purity:Min. 95%Molecular weight:200.2 g/mol[2-(5-Chloro-2-methoxyphenyl)ethynyl]trimethylsilane
CAS:Versatile small molecule scaffoldFormula:C12H15ClOSiPurity:Min. 95%Molecular weight:238.78 g/mol5-Ethyl-2-methoxyphenylboronic acid
CAS:Versatile small molecule scaffoldFormula:C9H13BO3Purity:Min. 95%Molecular weight:180.01 g/molEthyl 2-(2-methoxypyridin-4-yl)acetate
CAS:Versatile small molecule scaffoldFormula:C10H13NO3Purity:Min. 95%Molecular weight:195.21 g/mol1-(Pyridine-3-sulfonyl)piperidine-3-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C11H14N2O4SPurity:Min. 95%Molecular weight:270.31 g/mol(1s,3s)-3-[2-(tert-butoxy)-2-oxoethyl]cyclobutane-1-carboxylic acid, cis
CAS:Versatile small molecule scaffoldFormula:C11H18O4Purity:Min. 95%Molecular weight:214.3 g/molMethyl 2-(quinolin-3-yl)acetate
CAS:Versatile small molecule scaffold
Formula:C12H11NO2Purity:Min. 95%Molecular weight:201.22 g/moltert-butyl N-{[(prop-2-yn-1-yl)carbamoyl]methyl}carbamate
CAS:Versatile small molecule scaffoldFormula:C10H16N2O3Purity:Min. 95%Molecular weight:212.24 g/mol1-(2-Aminoethyl)piperidin-3-ol
CAS:Versatile small molecule scaffoldFormula:C7H16N2OPurity:Min. 95%Molecular weight:144.22 g/mol(3,4-Difluoro-2-methyl-phenyl)methanol
CAS:Versatile small molecule scaffoldFormula:C8H8F2OPurity:Min. 95%Molecular weight:158.14 g/molPropyl[2-(thiophen-2-yl)ethyl]amine
CAS:Versatile small molecule scaffoldFormula:C9H15NSPurity:Min. 95%Molecular weight:169.29 g/mol2-Iodo-5-methyl-1,3-thiazole
CAS:Versatile small molecule scaffold
Formula:C4H4NSIPurity:Min. 95%Molecular weight:225.05 g/mol2-[3-(4H-1,2,4-Triazol-4-yl)phenoxy]acetic acid
CAS:Versatile small molecule scaffoldFormula:C10H9N3O3Purity:Min. 95%Molecular weight:219.2 g/moltert-Butyl N-[3-(aminooxy)propyl]carbamate
CAS:Versatile small molecule scaffoldFormula:C8H18N2O3Purity:Min. 95%Molecular weight:190.24 g/mol3-Chloro-5-(chloromethyl)pyridine hydrochloride
CAS:Versatile small molecule scaffoldFormula:C6H5Cl2N·HClPurity:Min. 95%Molecular weight:198.48 g/mol2-Chloromethyl-5,6-difluoro-1H-benzoimidazole
CAS:Versatile small molecule scaffold
Formula:C8H5ClF2N2Purity:Min. 95%Molecular weight:202.59 g/mol2-Chloro-5-[(ethoxycarbonyl)amino]benzoic acid
CAS:Versatile small molecule scaffoldFormula:C10H10ClNO4Purity:Min. 95%Molecular weight:243.64 g/mol1,3-Bis[(2,2-dimethyl-1,3-dioxan-5-yl)oxy]-2-propanol
CAS:Versatile small molecule scaffoldFormula:C15H28O7Purity:Min. 95%Molecular weight:320.38 g/mol[1-(2-Fluoro-phenyl)-2-hydroxy-ethyl]-carbamic acid tert-butyl ester
CAS:Versatile small molecule scaffoldFormula:C13H18FNO3Purity:Min. 95%Molecular weight:255.28 g/mol8-Chloro-3-iodoquinoline
CAS:8-Chloro-3-iodoquinoline is a functionalized aromatic ring that is used in coupling reactions with aryl halides, such as bromides and iodides. Palladium-catalyzed coupling reactions are often more selective than those catalyzed by copper. 8-Chloro-3-iodoquinoline has been shown to be selectively coupled to bromide, which can be used for the synthesis of aryl bromides.Formula:C9H5ClINPurity:Min. 95%Molecular weight:289.5 g/mol(S)-Methyl 4-(1-aminoethyl)benzoate hydrochloride
CAS:Versatile small molecule scaffoldFormula:C10H13NO2·HClPurity:Min. 95%Molecular weight:215.68 g/mol4-(N-Methyl4-acetylbenzenesulfonamido)butanoic acid
CAS:Versatile small molecule scaffoldFormula:C13H17NO5SPurity:Min. 95%Molecular weight:299.34 g/mol[(4-Fluorophenyl)methyl](pentyl)amine
CAS:Versatile small molecule scaffoldFormula:C12H18FNPurity:Min. 95%Molecular weight:195.28 g/mol4-(3-Fluorophenyl)-5-(morpholin-4-yl)-4H-1,2,4-triazole-3-thiol
CAS:Versatile small molecule scaffoldFormula:C12H13FN4OSPurity:Min. 95%Molecular weight:280.32 g/mol4-(2-Methylphenyl)-5-(morpholin-4-yl)-4H-1,2,4-triazole-3-thiol
CAS:Versatile small molecule scaffoldFormula:C13H16N4OSPurity:Min. 95%Molecular weight:276.36 g/mol2-(4-tert-Butyl-2-methylphenoxymethyl)oxirane
CAS:Versatile small molecule scaffoldFormula:C14H20O2Purity:Min. 95%Molecular weight:220.31 g/mol(5-Ethoxy-2-methyl-2,3-dihydro-1-benzofuran-6-yl)methanamine
CAS:Versatile small molecule scaffoldFormula:C12H17NO2Purity:Min. 95%Molecular weight:207.27 g/mol6-Ethyl-7-hydroxy-3-(4-phenyl-4H-1,2,4-triazol-3-yl)-4H-chromen-4-one
CAS:Versatile small molecule scaffoldFormula:C19H15N3O3Purity:Min. 95%Molecular weight:333.3 g/mol2-Chloro-5-[methoxy(methyl)sulfamoyl]benzoic acid
CAS:Versatile small molecule scaffoldFormula:C9H10ClNO5SPurity:Min. 95%Molecular weight:279.7 g/mol4-[(Carbamoylmethyl)sulfamoyl]benzoic acid
CAS:Versatile small molecule scaffoldFormula:C9H10N2O5SPurity:Min. 95%Molecular weight:258.25 g/mol3-(Trimethoxymethyl)-1,2-dihydroisoquinolin-1-one
CAS:Versatile small molecule scaffold
Formula:C13H15NO4Purity:Min. 95%Molecular weight:249.26 g/mol2-((Dimethylcarbamoyl)methoxy)benzoic acid
CAS:Versatile small molecule scaffoldFormula:C11H13NO4Purity:Min. 95%Molecular weight:223.23 g/mol3-Ethyl-4-oxo-2-sulfanyl-3,4-dihydroquinazoline-7-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C11H10N2O3SPurity:Min. 95%Molecular weight:250.28 g/mol3-Methyl-4-oxo-2-sulfanyl-3,4-dihydroquinazoline-7-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C10H8N2O3SPurity:Min. 95%Molecular weight:236.25 g/mol3-[3-(4-Methylphenyl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]propanoic acid
CAS:Controlled Product3-[3-(4-Methylphenyl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]propanoic acid is a potent inhibitor of the transient receptor potential vanilloid 1 (TRPV1) ion channel. TRPV1 is a membrane protein activated by noxious heat or capsaicin and mediates responses to these stimuli. It also plays a role in inflammation and pain sensation. 3-[3-(4-Methylphenyl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]propanoic acid blocks TRPV1 channels by binding to its intracellular region and thereby preventing activation. This agent can be used as a research tool for studying TRPV1 channels in vitro and in vivo.Formula:C12H13N3O2SPurity:Min. 95%Molecular weight:263.32 g/mol5-(4-Fluorophenyl)-4-[2-(morpholin-4-yl)ethyl]-4H-1,2,4-triazole-3-thiol
CAS:Versatile small molecule scaffoldFormula:C14H17FN4OSPurity:Min. 95%Molecular weight:308.38 g/mol4-Benzyl-5-(morpholin-4-yl)-4H-1,2,4-triazole-3-thiol
CAS:Versatile small molecule scaffoldFormula:C13H16N4OSPurity:Min. 95%Molecular weight:276.36 g/mol4-(3-Methylphenyl)-5-(morpholin-4-yl)-4H-1,2,4-triazole-3-thiol
CAS:Versatile small molecule scaffoldFormula:C13H16N4OSPurity:Min. 95%Molecular weight:276.36 g/mol1-Morpholin-4-ylmethyl-propylamine
CAS:Versatile small molecule scaffoldFormula:C8H18N2OPurity:Min. 95%Molecular weight:158.25 g/mol(S)-6-(Hydroxymethyl)morpholin-3-one
CAS:Versatile small molecule scaffoldFormula:C5H9NO3Purity:Min. 95%Molecular weight:131.12 g/mol4-bromo-1-(2-methoxyethyl)-1H-pyrazole
CAS:4-bromo-1-(2-methoxyethyl)-1H-pyrazole is a potent and selective inhibitor of the enzyme tyrosine hydroxylase. It binds to the active site of the enzyme and inhibits its function, thereby reducing dopamine production and preventing the development of Parkinson's disease. The positioning and simulations were conducted using molecular dynamics techniques to determine the most probable binding site for this compound. The energy efficiency was calculated by comparing the free energy of activation for 4-bromo-1-(2-methoxyethyl)-1H-pyrazole with that of other inhibitors. Mathematical models have been developed to simulate how these inhibitors are able to bind to tyrosine hydroxylase in order to inhibit dopamine production. This has led to a better understanding of dyskinesia, which is a symptom of Parkinson's disease, and methods for controlling it. The profile and trajectory data were collected from an autonomous underwater vehicle (AUV)Formula:C6H9BrN2OPurity:Min. 95%Molecular weight:205.06 g/mol[2-(4-Bromopyrazol-1-yl)ethyl]dimethylamine
CAS:Versatile small molecule scaffoldFormula:C7H12BrN3Purity:Min. 95%Molecular weight:218.09 g/mol1-Ethyl-2,5-dimethyl-1H-pyrrole-3-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C9H13NO2Purity:Min. 95%Molecular weight:167.2 g/mol5-(Ethanesulfonyl)-2-methyl-1,3-benzoxazole
CAS:Versatile small molecule scaffold
Formula:C10H11NO3SPurity:Min. 95%Molecular weight:225.27 g/mol
